Tyrosine phosphorylation by Src within the cavity of the adenine nucleotide translocase 1 regulates ADP/ATP exchange in mitochondria. 2010

Jianhua Feng, and Eliana Lucchinetti, and Giray Enkavi, and Yi Wang, and Peter Gehrig, and Bernd Roschitzki, and Marcus C Schaub, and Emad Tajkhorshid, and Kathrin Zaugg, and Michael Zaugg
Dept. of Anesthesiology and Pain Medicine, Univ. of Alberta, Clinical Sciences Bldg. Rm. 8-120, 113 St. 83 Ave., Edmonton, AB T6G 2G3, Canada.

Phosphorylation of adenine nucleotide translocator 1 (ANT1) at residue Y194, which is part of the aromatic ladder located within the lumen of the carrier, critically regulates mitochondrial metabolism. Recent data support the concept that members of the Src family of nonreceptor tyrosine kinases are constitutively present in mitochondria and key to regulation of mitochondrial function. Herein, we demonstrate that site mutations of ANT1 (Y190-->F190, Y194-->F194) mimicking dephosphorylation of the aromatic ladder resulted in loss of oxidative growth and ADP/ATP exchange activity in respiration-incompetent yeast expressing mutant chimeric yN-hANT1. ANT1 is phosphorylated at Y194 by the Src family kinase members Src and Lck, and increased phosphorylation is tightly linked to reduced cell injury in preconditioned protected vs. unprotected cardiac mitochondria. Molecular dynamics simulations find the overall structure of the phosphorylated ANT1 stable, but with an increased steric flexibility in the region of the aromatic ladder, matrix loop m2, and four helix-linking regions. Combined with an analysis of the putative cytosolic salt bridge network, we reason that the effect of phosphorylation on transport is likely due to an accelerated transition between the main two conformational states (c<-->m) of the carrier during the transport cycle. Since "aromatic signatures" are typical for other mitochondrial carrier proteins with important biological functions, our results may be more general and applicable to these carriers.

UI MeSH Term Description Entries
D008928 Mitochondria Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed) Mitochondrial Contraction,Mitochondrion,Contraction, Mitochondrial,Contractions, Mitochondrial,Mitochondrial Contractions
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011499 Protein Processing, Post-Translational Any of various enzymatically catalyzed post-translational modifications of PEPTIDES or PROTEINS in the cell of origin. These modifications include carboxylation; HYDROXYLATION; ACETYLATION; PHOSPHORYLATION; METHYLATION; GLYCOSYLATION; ubiquitination; oxidation; proteolysis; and crosslinking and result in changes in molecular weight and electrophoretic motility. Amino Acid Modification, Post-Translational,Post-Translational Modification,Post-Translational Protein Modification,Posttranslational Modification,Protein Modification, Post-Translational,Amino Acid Modification, Posttranslational,Post-Translational Amino Acid Modification,Post-Translational Modifications,Post-Translational Protein Processing,Posttranslational Amino Acid Modification,Posttranslational Modifications,Posttranslational Protein Processing,Protein Processing, Post Translational,Protein Processing, Posttranslational,Amino Acid Modification, Post Translational,Modification, Post-Translational,Modification, Post-Translational Protein,Modification, Posttranslational,Modifications, Post-Translational,Modifications, Post-Translational Protein,Modifications, Posttranslational,Post Translational Amino Acid Modification,Post Translational Modification,Post Translational Modifications,Post Translational Protein Modification,Post Translational Protein Processing,Post-Translational Protein Modifications,Processing, Post-Translational Protein,Processing, Posttranslational Protein,Protein Modification, Post Translational,Protein Modifications, Post-Translational
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer

Related Publications

Jianhua Feng, and Eliana Lucchinetti, and Giray Enkavi, and Yi Wang, and Peter Gehrig, and Bernd Roschitzki, and Marcus C Schaub, and Emad Tajkhorshid, and Kathrin Zaugg, and Michael Zaugg
December 2009, The FEBS journal,
Jianhua Feng, and Eliana Lucchinetti, and Giray Enkavi, and Yi Wang, and Peter Gehrig, and Bernd Roschitzki, and Marcus C Schaub, and Emad Tajkhorshid, and Kathrin Zaugg, and Michael Zaugg
November 2019, Nature,
Jianhua Feng, and Eliana Lucchinetti, and Giray Enkavi, and Yi Wang, and Peter Gehrig, and Bernd Roschitzki, and Marcus C Schaub, and Emad Tajkhorshid, and Kathrin Zaugg, and Michael Zaugg
April 2020, Biomolecules,
Jianhua Feng, and Eliana Lucchinetti, and Giray Enkavi, and Yi Wang, and Peter Gehrig, and Bernd Roschitzki, and Marcus C Schaub, and Emad Tajkhorshid, and Kathrin Zaugg, and Michael Zaugg
January 2022, Bioscience, biotechnology, and biochemistry,
Jianhua Feng, and Eliana Lucchinetti, and Giray Enkavi, and Yi Wang, and Peter Gehrig, and Bernd Roschitzki, and Marcus C Schaub, and Emad Tajkhorshid, and Kathrin Zaugg, and Michael Zaugg
October 1988, Biological chemistry Hoppe-Seyler,
Jianhua Feng, and Eliana Lucchinetti, and Giray Enkavi, and Yi Wang, and Peter Gehrig, and Bernd Roschitzki, and Marcus C Schaub, and Emad Tajkhorshid, and Kathrin Zaugg, and Michael Zaugg
January 1982, The Journal of biological chemistry,
Jianhua Feng, and Eliana Lucchinetti, and Giray Enkavi, and Yi Wang, and Peter Gehrig, and Bernd Roschitzki, and Marcus C Schaub, and Emad Tajkhorshid, and Kathrin Zaugg, and Michael Zaugg
June 1973, Biochimica et biophysica acta,
Jianhua Feng, and Eliana Lucchinetti, and Giray Enkavi, and Yi Wang, and Peter Gehrig, and Bernd Roschitzki, and Marcus C Schaub, and Emad Tajkhorshid, and Kathrin Zaugg, and Michael Zaugg
June 1972, FEBS letters,
Jianhua Feng, and Eliana Lucchinetti, and Giray Enkavi, and Yi Wang, and Peter Gehrig, and Bernd Roschitzki, and Marcus C Schaub, and Emad Tajkhorshid, and Kathrin Zaugg, and Michael Zaugg
February 1972, FEBS letters,
Jianhua Feng, and Eliana Lucchinetti, and Giray Enkavi, and Yi Wang, and Peter Gehrig, and Bernd Roschitzki, and Marcus C Schaub, and Emad Tajkhorshid, and Kathrin Zaugg, and Michael Zaugg
May 1984, Biochemistry,
Copied contents to your clipboard!